280 related articles for article (PubMed ID: 28507448)
1. Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response.
Abaji R; Krajinovic M
Pharmgenomics Pers Med; 2017; 10():143-156. PubMed ID: 28507448
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacogenomics of thiopurine S-methyltransferase.
Zhou S
Curr Clin Pharmacol; 2006 Jan; 1(1):119-28. PubMed ID: 18666383
[TBL] [Abstract][Full Text] [Related]
3. Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.
Chouchana L; Narjoz C; Beaune P; Loriot MA; Roblin X
Aliment Pharmacol Ther; 2012 Jan; 35(1):15-36. PubMed ID: 22050052
[TBL] [Abstract][Full Text] [Related]
4. Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.
Karas-Kuzelicki N; Mlinaric-Rascan I
Pharmacogenomics; 2009 Aug; 10(8):1309-22. PubMed ID: 19663675
[TBL] [Abstract][Full Text] [Related]
5. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
[TBL] [Abstract][Full Text] [Related]
6. Thiopurine S-methyltransferase pharmacogenetics in childhood acute lymphoblastic leukemia.
Yang JJ; Bhojwani D
Methods Mol Biol; 2013; 999():273-84. PubMed ID: 23666706
[TBL] [Abstract][Full Text] [Related]
7. The Role of Pharmacogenetics in the Therapeutic Response to Thiopurines in the Treatment of Inflammatory Bowel Disease: A Systematic Review.
Ribeiro AC; Gerheim PSAS; Chebli JMF; Nascimento JWL; de Faria Pinto P
J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959208
[TBL] [Abstract][Full Text] [Related]
8. Beyond TPMT: genetic influences on thiopurine drug responses in inflammatory bowel disease.
Roberts RL; Gearry RB; Kennedy MA; Barclay ML
Per Med; 2008 May; 5(3):233-248. PubMed ID: 29783500
[TBL] [Abstract][Full Text] [Related]
9. Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis.
Liu YP; Wu HY; Yang X; Xu HQ; Li YC; Shi DC; Huang JF; Huang Q; Fu WL
PLoS One; 2015; 10(3):e0121745. PubMed ID: 25799415
[TBL] [Abstract][Full Text] [Related]
10. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
Gearry RB; Barclay ML
J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
[TBL] [Abstract][Full Text] [Related]
11. Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia.
Stocco G; Franca R; Verzegnassi F; Londero M; Rabusin M; Decorti G
Front Genet; 2012; 3():309. PubMed ID: 23335936
[TBL] [Abstract][Full Text] [Related]
12. Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics.
Lennard L; Cartwright CS; Wade R; Vora A
Br J Haematol; 2015 Apr; 169(2):228-40. PubMed ID: 25441457
[TBL] [Abstract][Full Text] [Related]
13. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia.
Dokmanovic L; Urosevic J; Janic D; Jovanovic N; Petrucev B; Tosic N; Pavlovic S
Ther Drug Monit; 2006 Dec; 28(6):800-6. PubMed ID: 17164697
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive study of thiopurine methyltransferase genotype, phenotype, and genotype-phenotype discrepancies in Sweden.
Zimdahl Kahlin A; Helander S; Skoglund K; Söderkvist P; Mårtensson LG; Appell ML
Biochem Pharmacol; 2019 Jun; 164():263-272. PubMed ID: 31005613
[TBL] [Abstract][Full Text] [Related]
15. Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations.
Lennard L; Van Loon JA; Lilleyman JS; Weinshilboum RM
Clin Pharmacol Ther; 1987 Jan; 41(1):18-25. PubMed ID: 3467886
[TBL] [Abstract][Full Text] [Related]
16. Comparison of three methods for measuring thiopurine methyltransferase activity in red blood cells and human leukemia cells.
Karim H; Appell ML; Fotoohi A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():80-5. PubMed ID: 24113235
[TBL] [Abstract][Full Text] [Related]
17. Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase.
Weinshilboum R
Drug Metab Dispos; 2001 Apr; 29(4 Pt 2):601-5. PubMed ID: 11259360
[TBL] [Abstract][Full Text] [Related]
18. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
19. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.
Hlavaty T; Batovsky M; Balakova D; Pav I; Celec P; Gregus M; Zakuciova M; Hlista M; Horakova M; Desatova B; Koller T; Toth J; Kadasi L; Huorka M;
Bratisl Lek Listy; 2013; 114(4):199-205. PubMed ID: 23514552
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the pharmacogenomics of thiopurine methyltransferase.
Coulthard SA; Hall AG
Pharmacogenomics J; 2001; 1(4):254-61. PubMed ID: 11908768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]